Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS Coronavirus (SARS-CoV-2) Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04745416
What this trial is testing

Clinical Characteristics of Patients With Leukemia and COVID-19

Who this might be right for
Leukemia, AcuteCovid19Leukemia, Lymphoblastic
Hospital General de Mexico 30
Not applicableStudy completedNCT04584658
What this trial is testing

Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study)

Who this might be right for
DysphagiaDysphoniaSubglottic Stenosis+7 more
Cambridge University Hospitals NHS Foundation Trust 50
Not applicableWithdrawnNCT04403035
What this trial is testing

Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19

Who this might be right for
Covid-19
Henry Ford Health System
Testing effectiveness (Phase 2)Study completedNCT05485584
What this trial is testing

RSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sichuan Huiyang Life Science and Technology Corporation 188
Testing effectiveness (Phase 2)UnknownNCT04708340
What this trial is testing

Tolerability and Efficacy of RJX in Patients With COVID-19

Who this might be right for
COVID-19Acute Respiratory Distress SyndromeSARS-CoV-2+1 more
Reven Pharmaceuticals, Inc. 237
Early research (Phase 1)Study completedNCT04522089
What this trial is testing

Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine

Who this might be right for
COVID-19
Adimmune Corporation 68
Early research (Phase 1)Study completedNCT06693518
What this trial is testing

Learn About if the Study Medicine Called Ibuzatrelvir Changes How the Body Process the Other Medicine Dabigatran Etexilate in Healthy Adults

Who this might be right for
SARS-CoV-2 Infections
Pfizer 20
Large-scale testing (Phase 3)Study completedNCT06729606
What this trial is testing

Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Who this might be right for
Covid19
National Institute of Allergy and Infectious Diseases (NIAID) 471
Not applicableUnknownNCT04366206
What this trial is testing

Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est

Who this might be right for
COVIDSARS-CoV 2
Centre Hospitalier Intercommunal Robert Ballanger 143
Not applicableStudy completedNCT05148806
What this trial is testing

Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies

Who this might be right for
Solid Organ Transplant RecipientsAutoimmune DiseasesHaematological Malignancies
Imperial College London 28,411
Not applicableStudy completedNCT04937621
What this trial is testing

Study of Arrhythmia and ECG Abnormalities in Patients With COVID-19

Who this might be right for
ArrhythmiaSARS-CoV-2 Infection
University Hospital, Bordeaux 196
Not applicableStudy completedNCT04445506
What this trial is testing

Short Term Corticosteroids in SARS-CoV2 Patients

Who this might be right for
CorticosteroidsCovid19SARS-CoV 2+2 more
The Miriam Hospital 50
Not applicableStudy completedNCT05687877
What this trial is testing

Evusheld Japan PMS_Japan Post-Marketing Surveillance (PMS)

Who this might be right for
SARS-CoV-2 Infection
AstraZeneca 366
Testing effectiveness (Phase 2)Study completedNCT04551898
What this trial is testing

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19
BeiGene 181
Large-scale testing (Phase 3)Study completedNCT04685512
What this trial is testing

Effect of Tenofovir/Emtricitabine in Patients Recently Infected With SARS-COV2 (Covid-19) Discharged Home

Who this might be right for
Covid19
University Hospital, Caen 60
Large-scale testing (Phase 3)Study completedNCT04379336
What this trial is testing

BCG Vaccination for Healthcare Workers in COVID-19 Pandemic

Who this might be right for
COVID-19Sars-CoV2
TASK Applied Science 1,000
Early research (Phase 1)Study completedNCT04933864
What this trial is testing

COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy

Who this might be right for
SARS-CoV-2
I.M. Sechenov First Moscow State Medical University 60
Not applicableStudy completedNCT05060510
What this trial is testing

The School SPIT Study - COVID-19 Testing in Secondary Schools

Who this might be right for
SARS-CoV2 Infection
The Hospital for Sick Children 60
Not applicableUnknownNCT04462120
What this trial is testing

IL-12RB and TNF-alpha Gene Polymorphism and Susceptibility and Progress of Covid-19 SARS-CoV-2: A Case Control Study

Who this might be right for
Covid-19
Assiut University 100
Testing effectiveness (Phase 2)Ended earlyNCT04433546
What this trial is testing

Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).

Who this might be right for
Acute Respiratory Distress SyndromeCoronavirusHypoxic Respiratory Failure+15 more
PhaseBio Pharmaceuticals Inc. 54
Next Page